Naproxen-eudragit® RS100 nanoparticles: Preparation and physicochemical characterization

Colloids and Surfaces B: Biointerfaces

Volumn 83, Issue 1, 2011, Pages 155-159

  Adibkia, Khosro ^a,b   Javadzadeh, Yousef ^a,b   Dastmalchi, Siavoush ^a,b   Mohammadi, Ghobad ^c   Niri, Fatemeh Kari ^a   Alaei Beirami, Mahmood ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMANSHAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Eudragit RS100; Nanoparticles; Naproxen; Physicochemical characteristics

Indexed keywords

ANTI-INFLAMMATORY EFFECTS; AQUEOUS PHASE; BURST RELEASE; CRYSTALLINITIES; EUDRAGIT; FT-IR SPECTRUM; INTERMOLECULAR INTERACTIONS; NAPROXENS; PHYSICAL MIXTURES; PHYSICO-CHEMICAL CHARACTERIZATION; PHYSICOCHEMICAL CHARACTERISTICS; PROCESS PARAMETERS; RELEASE PATTERN; RELEASE RATE;

DIFFERENTIAL SCANNING CALORIMETRY; EMULSIFICATION; FOURIER TRANSFORM INFRARED SPECTROSCOPY; FOURIER TRANSFORMS; PARTICLE SIZE ANALYSIS; SCANNING ELECTRON MICROSCOPY; X RAY CRYSTALLOGRAPHY;

NANOPARTICLES;

EUDRAGIT; EUDRAGIT RS; NANOPARTICLE; NAPROXEN; ACRYLIC ACID RESIN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG FORMULATION; DRUG QUALITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; MOLECULAR INTERACTION; NANOEMULSION; NANOFABRICATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITY CONTROL; SCANNING ELECTRON MICROSCOPY; SLOW DRUG RELEASE; STRUCTURE ANALYSIS; X RAY CRYSTALLOGRAPHY; CHEMISTRY; ULTRASTRUCTURE; X RAY DIFFRACTION;

ACRYLIC RESINS; CALORIMETRY, DIFFERENTIAL SCANNING; NANOPARTICLES; NAPROXEN; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 78650221912     PISSN: 09277765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2010.11.014     Document Type: Article

References (27)

1. Hornig S., Bunjes H., Heinze T. J. Colloid Interface Sci. 2009, 338:56-62.
2. Lee V.H. Adv. Drug Deliv. Rev. 2004, 56:1527-1528.
3. Barzegar-Jalali M., Adibkia K., Valizadeh H., Shadbad M.R., Nokhodchi A., Omidi Y., Mohammadi G., Nezhadi S.H., Hasan M. J. Pharm. Pharm. Sci. 2008, 11:167-177.
4. Bodmeier R., Chen H. J. Control. Release 1989, 10:167-175.
5. Dillen K., Vandervoort J., Van den M.G., Ludwig A. Int. J. Pharm. 2006, 314:72-82.
6. Perumal D., Dangor C.M., Alcock R.S., Hurbans N., Moopanar K.R. J. Microencapsul. 1999, 16:475-487.
7. Adibkia K., Siahi Shadbad M.R., Nokhodchi A., Javadzedeh A., Barzegar-Jalali M., Barar J., Mohammadi G., Omidi Y. J. Drug Target. 2007, 15:407-416.
8. Pignatello R., Bucolo C., Spedalieri G., Maltese A., Puglisi G. Biomaterials 2002, 23:3247-3255.
9. Pignatello R., Bucolo C., Ferrara P., Maltese A., Puleo A., Puglisi G. Eur. J. Pharm. Sci. 2002, 16:53-61.
10. Adibkia K., Omidi Y., Siahi M.R., Javadzadeh A.R., Barzegar-Jalali M., Barar J., Maleki N., Mohammadi G., Nokhodchi A. J. Ocul. Pharmacol. Ther. 2007, 23:421-432.
11. Rodrigues M.R., Lanzarini C.M., Ricci-Junior E. Pharm. Dev. Technol. 2009.
12. Wiseman H.L., Chang Y.H., Lombardino J.G. Arznneim. Forsch. Drug Res. 1976, 26:1300-1303.
13. Gieldanowski J. Arch Immunol. Ther. Exp. (Warsz.) 1988, 36:229-237.
14. Bucolo C., Maltese A., Maugeri F., Busa B., Puglisi G., Pignatello R. J. Pharm. Pharmacol. 2004, 56:841-846.
15. Jain R.A. Biomaterials 2000, 21:2475-2490.
16. Ubrich N., Bouillot P., Pellerin C., Hoffman M., Maincent P. J. Control. Release 2004, 97:291-300.
17. Kopade A.J., Jain N.K. Pharmazie 1995, 50:812-814.
18. Kawashima Y., Niwa T., Handa T., Takeuchi H., Iwamoto T., Itoh K. J. Pharm. Sci. 1989, 78:68-72.
19. Mainardes R.M., Evangelista R.C. Int. J. Pharm. 2005, 290:137-144.
20. Mura P., Bettinetti G.P., Cirri M., Maestrelli F., Sorrenti M., Catenacci L. Eur. J. Pharm. Biopharm. 2005, 59:99-106.
21. Mura P., Faucci M.T., Bettinetti G.P. Eur. J. Pharm. Sci. 2001, 13:187-194.
22. Tiong N., Elkordy A.A. Eur. J. Pharm. Biopharm. 2009, 73:373-384.
23. Bhise K.S., Dhumal R.S., Paradkar A.R., Kadam S.S. AAPS PharmSciTech 2008, 9:1-12.
24. Douglas S.J., Davis S.S., Illum L. Crit. Rev. Ther. Drug Carrier Syst. 1987, 3:233-261.
25. Leo E., Forni F., Bernabei M.T. Int. J. Pharm. 2000, 196:1-9.
26. Kim D.H., Martin D.C. Biomaterials 2006, 27:3031-3037.
27. Bhaskar K., Anbu J., Ravichandiran V., Venkateswarlu V., Rao Y.M. Lipids Health Dis. 2009, 8:6.